Skip to content

Newsroom

Connect with trending topics, events, the industry's best thinkers, news and information.

05/21/2020

Allscripts U.K. client Gloucestershire Hospitals achieves successful go-live with e-observations solution amidst COVID-19 pandemic

NHS Foundation Trust deploys new EHR functionality to identify and escalate treatment for its sickest patients; Allscripts creates a Go-Live Virtual Office to provide 24/7 remote go-live support

CHICAGO–(BUSINESS WIRE)–May 21, 2020–
Gloucestershire Hospitals NHS Foundation Trust, located in the United Kingdom, has successfully gone live with the latest addition to its Allscripts electronic health record, despite the ongoing novel coronavirus outbreak.

The Trust decided to deploy the Sunrise EHR as a ‘clinical wrap’ around its existing patient administration system last year and went live with nursing documentation and risk assessments just five months later.

On March 17, 2020, the Trust added the e-observations functionality, which includes automatic calculation of NEWS2, the national early warning score designed to pick up patients at risk of deterioration. The implementation of NEWS2 is immediately helping the Trust manage patients during the COVID-19 outbreak. Gloucestershire Hospitals has also added icons to its patient tracking board to identify patients with COVID-19 and made results available through the system.

“At a time when we were in the midst of COVID-19 planning, I was unbelievably proud of our nursing staff for their impressive implementation of e-observations and commitment to making it work. This has been good for our patients and good for our clinical teams,” said Professor Steve Hams, the Trust’s Director of Quality and Chief Nurse.

“We knew that moving patient observations to Sunrise EHR would bring huge benefits in our two acute hospitals and had planned our launch for March. So when the COVID-19 pandemic hit the UK, we needed to make a quick decision about whether or not to go ahead. We held our nerve and put extra staff on our wards to make sure we got this right, at a challenging time for our hospitals,” said Mark Hutchinson, executive CDIO.

“Having e-observations in place has proved essential in managing our patients during the coronavirus pandemic. Our acute care response teams are able to manage caseloads, senior nursing staff can use the data to manage staffing deployment, and we’re able to track the numbers and locations of patients who are being supported by oxygen.”

The Allscripts U.K. team has moved fast to support Trusts like Gloucestershire Hospitals that want to proceed with go-lives that will help their staff and patients through the pandemic. It has created a Go-Live Virtual Office with a 24/7 virtual meeting room with voice and video capability, structured documents and screen sharing tools.

The office is connected to a floorwalking messaging app, so team members can be aware of issues as they are identified on wards and clinics, before they are logged into help-desk systems.

For the Gloucestershire Hospitals go-live, the virtual office was staffed with a wide range of team members based in different countries around the globe, so the Trust team could visit at any time.

“As NHS acute Trusts begin to deal with more and more people with COVID-19, the flexibility of Sunrise is proving to be a key tool for helping them to identify and manage these patients,” said Richard Strong, Allscripts Managing Director, EMEA. “It was a brave decision for Gloucestershire Hospitals NHS Foundation Trust to introduce new functionality to record patient observations and escalate the management of deteriorating patients amid the huge organizational change required to prepare for the pandemic. But it was absolutely the right decision, and one Allscripts was determined to support. We moved rapidly to new ways of working to fully support go-lives 24/7, without risking the health of our staff, NHS staff or patients by undertaking traditional support and floor-walking activities. We were already moving toward this way of working before the COVID-19 shutdown, but we accelerated our schedule to push through remote working in time for the Gloucestershire Hospitals go-live. We are now using these tools to support other NHS customers that want to go-ahead with functionality that will help them, their staff and patients at this exceptionally difficult time.”

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2020 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Investors:

Stephen Shulstein

312-386-6735

Stephen.Shulstein@allscripts.com

Media:

Concetta Rasiarmos

312-447-2466

concetta.rasiarmos@allscripts.com

Source: Allscripts

05/19/2020

Sunnybrook Health Sciences Centre Extends Relationship with Allscripts, Incorporating Allscripts Census Logic Analytics and Managed Services

Sunnybrook Health Sciences Centre in Toronto, Canada, to implement Allscripts Managed Services and Allscripts Census Logic solution to improve patient flow

TORONTO–(BUSINESS WIRE)–May 19, 2020–
Allscripts Healthcare Solutions (NASDAQ: MDRX) today announces that Canada’s Sunnybrook Health Sciences Centre has extended its relationship with Allscripts for an additional seven years to provide software and support for Allscripts Patient Flow. This extension includes the purchase by Sunnybrook of Allscripts Managed Services to manage the Patient Flow solution 24 hours, seven days a week and 365 days a year. The Allscripts Managed Services team will optimize the solution, implement customizations and new functionality and assist with change control and expansion activities.

Sunnybrook and Allscripts have partnered since March of 2009, utilizing the Allscripts Patient Flow solution to manage beds and patient movement throughout the hospital system. Sunnybrook Health Sciences Centre began as a hospital for Canadian veterans and has since grown into a fully affiliated teaching hospital of the University of Toronto, evolving to meet the needs of its growing community. The hospital sees nearly 1.3 million patients each year across three campuses and is also home to Canada’s largest trauma centre. Sunnybrook’s groundbreaking research changes the way patients are treated around the world.

With the expanded seven-year commitment to Allscripts Patient Flow, Sunnybrook will take advantage of two new solution components. First, a Transfer Centre component, which supports efficient handling of unplanned and emergent admissions by enabling the quick capture of relevant caller and patient information with the ability to rapidly ascertain bed availability within a single hospital, or across the multiple facilities of Sunnybrook. Second, Allscripts Census Logic, an analytics component providing full-stack descriptive, predictive and prescriptive analytics to help Sunnybrook make evidence-based decisions and improve current and future patient flow challenges. Allscripts Census Logic also provides a unified operational scorecard, forecasts of census and inpatient throughput, suggestions for staffing levels based on history and predicted demand, and patient-level identification of outliers and potential bottlenecks.

“Having a bed management system with enhanced analytic capabilities enables quick assignment and discharge, along with automated dispatching for housekeeping to turn over beds and real time transport requests to ensure efficient movement of patients throughout the hospital system.” “We believe our extended partnership with Allscripts will provide us with the most comprehensive solutions for Sunnybrook’s continued success,” said Sam Marafioti, Sunnybrook’s Vice President, Capital/Chief Information Officer.

“We’ve had a long-standing partnership with Sunnybrook and were excited to extend our software and services to them for another seven years,” said Allscripts CEO Paul Black. “We have shared many successes within the partnership. This expansion incorporating managed services and Allscripts Census Logic platform will warrant that many more achievements are yet to come for Sunnybrook and the community it serves.”

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2020 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Investors:

Stephen Shulstein

312-386-6735

Stephen.Shulstein@allscripts.com

Media:

Concetta Rasiarmos

312-447-2466

concetta.rasiarmos@allscripts.com

Source: Allscripts Healthcare Solutions

05/14/2020

Allscripts Receives Top Rankings From Black Book™ Research

Annual client satisfaction survey results reveal company receives high rankings in both ambulatory and acute settings

CHICAGO–(BUSINESS WIRE)–May 14, 2020–
Allscripts (NASDAQ: MDRX) has been recognized as the top-rated electronic health record vendor for ambulatory practices and inpatient hospitals according to new survey results from Black Book Research. The annual client satisfaction survey features responses collected from more than 2,000 individual users of electronic health record platforms in the U.S. and are collected from all areas of the organization including IT, administrative staff and end-user clinicians.

“Allscripts has addressed the ambulatory and acute markets effectively with its electronic health record and practice management solutions, supplying an unparalleled client base with solution breadth and depth,” said Doug Brown, Managing Partner and President, Black Book. “The positive results from this survey show that the physicians and staff across the U.S. using these solutions feel well-served as these solutions continue to meet their unique needs.”

First-Place Awards

  • Hospitals 101-250 beds for the fourth consecutive year
  • Rehabilitation hospitals for the second consecutive year
  • Integrated Practice management for hospital systems and IDNs
  • Integrated Ambulatory EHR/Practice Management
  • Ambulatory Practices 26-99 providers for the seventh consecutive year

Second-Place Awards

  • Hospitals 100 beds or less
  • Ambulatory practices with 6-10 physicians
  • Ambulatory practices over 100 physicians
  • Practice management solutions for groups with 50+ physicians
  • Multispecialty clinics
  • Physical therapy/rehab facilities

Third-Place Awards

  • Large hospitals over 251 beds
  • Hospital EHR, academic medical centers and regional networks
  • Specialty Ambulatory Practices including Urgent Care, Cardiology, Endocrinology and Nephrology

“Black Book’s comprehensive survey shows the broad reach of our solution portfolio and steadfast commitment to our clients’ success. In addition to these consistently high rankings, I am most proud of the fact the survey has rated us #1 in trust for 8 years straight,” said Paul Black, Allscripts CEO. “Just as patients must trust their caregivers, healthcare organizations must trust their HCIT supplier to provide solutions that share their mission to provide the best care possible for the patients in their communities. Relationships with our clients matter and we are honored to serve as our clients’ trusted partner.”

Black Book Research is a full-service healthcare-centric market research and public opinion research company and premier provider of competitive intelligence, market research, opinion mining, sentiment analysis, services evaluation and strategic consulting services to companies worldwide. To ensure survey integrity and accurate, comprehensive results, Black Book’s comprehensive methodology is crowd-sourced and represents a broad spectrum of solution users. Survey responses go through both internal and external audits, ensuring completeness, accuracy and validity. For more information, visit www.blackbookmarketresearch.com.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2020 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Investors:

Stephen Shulstein

312-386-6735

Stephen.Shulstein@allscripts.com

Media:

Concetta Rasiarmos

312-447-2466

concetta.rasiarmos@allscripts.com

Source: Allscripts Healthcare, LLC

05/12/2020

Veradigm, Surescripts Partner to Reduce Time-to-Fill for Specialty Medication Prescriptions

Agreement facilitating the accelerated fulfillment for hundreds more specialty medications across one of healthcare’s largest provider networks

CHICAGO–(BUSINESS WIRE)–May 12, 2020–
Allscripts (NASDAQ: MDRX) business unit Veradigm™, a leading provider of data and technology solutions, today announced the signing of an agreement with Surescripts to enhance its Veradigm AccelRx™ specialty medication fulfillment solution with Surescripts Specialty Patient Enrollment. The agreement will enable AccelRx to support healthcare providers in more quickly fulfilling prescriptions for hundreds more types of specialty medications by incorporating Surescripts’ expansive health information network, further streamlining healthcare providers’ management of specialty medication within their electronic health record workflow.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200512005301/en/

Representing less than 3% of all prescriptions written in the U.S. in 2020, specialty medications are expected to account for up to 50% of the total drug spend.1 To receive their specialty medication, a patient’s prescription must pass through a broad cross-section of healthcare stakeholders, from biopharma companies and payers, to specialty pharmacies and specialty medication hubs. Each of these entities may have their own, standalone online portal for facilitating fulfilment for a single drug or manufacturer. With so many manufacturers and payers directly involved in the delivery of specialty medications, it can be easy for providers and even specialty medication hubs to be overwhelmed.

The result is often that instead of taking days to receive their specialty medication, it takes weeks or even months. Despite this rapid growth, recent data from Veradigm has shown that specialty drugs are 50% less likely to be electronically prescribed.2

Combining one of healthcare’s largest prescriber bases with broad industry partnerships built over decades of e-prescribing and prior authorization leadership, Veradigm AccelRx delivers a unique software platform designed to streamline specialty medication fulfillment.

“Veradigm is excited to join with Surescripts in strengthening the ability of Allscripts’ network of healthcare providers to reduce or eliminate the many phone calls and faxes associated with enrolling patients for specialty medication prescriptions,” says Tom Langan, Veradigm CEO. “In our unique position at the nexus of point-of-care patient solutions and clinical data insight, our many biopharma and payer partners are looking to us for support in streamlining this process. With this agreement, Veradigm AccelRx will be enabled to deliver a solution for hundreds of specialty medications and help us rapidly progress toward our goal of covering every specialty medication for every therapeutic area.”

By enabling providers to enroll patients into specialty programs in the EHR and coordinating information sent to the pharmacy, while the patient is still in their office, Veradigm AccelRx, in collaboration with partners like Surescripts, delivers the tools providers need to overcome the existing gaps and speed up the specialty medication fulfillment process.

“When we replace manual work with an accurate, electronic workflow, patients get essential therapies sooner and providers have more time to do what matters most, help patients,” said Mike Pritts, Surescripts Chief Product Officer. “Together with Veradigm, we can help drive meaningful change for all providers using AccelRx to accelerate and simplify specialty medication enrollment to the pharmacy and specialty medication hub.”

Learn more about the Veradigm AccelRx solution here.

1. Pharmaceutical Executive. 2015 Pharm Science Strategic Outlook. 2015.

2. Data on file. 2019.

About Veradigm™

Veradigm is an integrated data systems and services company that combines data-driven clinical insights with actionable tools to help healthcare stakeholders improve the quality, efficiency, and value of healthcare delivery — including biopharma, health plans, healthcare providers, health technology partners, and most importantly, the patients they serve. We are dedicated to simplifying the complicated healthcare system with next-generation healthcare solutions. This is how we are transforming health, insightfully. To learn more, visit www.veradigmhealth.com.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2020 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Investors:

Stephen Shulstein

312-386-6735

Stephen.Shulstein@allscripts.com

Media:

Concetta Rasiarmos

312-447-2466

concetta.rasiarmos@allscripts.com

Source: Allscripts Healthcare, LLC

05/07/2020

Allscripts Announces First Quarter 2020 Results
  • First quarter 2020 bookings of $205 million, above high end of outlook range

CHICAGO–(BUSINESS WIRE)–May 7, 2020–
Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) announced its financial results for the three months ended March 31, 2020.

Bookings(1) were $205 million in the first quarter of 2020. This result compares with $286 million in the first quarter of 2019. Contract revenue backlog totaled $4.5 billion as of March 31, 2020.

First quarter 2020 revenue was $417 million compared with $432 million in the first quarter of 2019.

On a GAAP basis in the first quarter of 2020 total operating expenses were $166 million compared with $171 million in the first quarter of 2019. Non-GAAP operating expenses in the first quarter of 2020 and 2019 both totaled $145 million.

GAAP net loss in the first quarter of 2020 totaled $20 million compared with net loss of $8 million in the first quarter of 2019. Non-GAAP net income in the first quarter of 2020 totaled $15 million compared with $27 million in the first quarter of 2019.

GAAP loss per share in the first quarter of 2020 was $0.13 compared with loss per share of $0.04 in the first quarter of 2019. Non-GAAP diluted earnings per share in the first quarter of 2020 were $0.09 compared with $0.16 in the first quarter of 2019.

“Our first quarter results show continued strength in new bookings, which reflects the confidence our clients have in our solutions,” commented Paul M. Black, Allscripts Chief Executive Officer. “The COVID-19 pandemic has created challenges for our clients and thus for our business. The pandemic accentuates the importance of mission-critical EMR solutions, and the value of actionable real time data and analytics to better care for a new cohort of critically ill patients. I am extremely proud of the work we are doing to provide excellent support for our clients and implement new and innovative solutions, addressing this pandemic around the globe. Looking ahead, we believe Allscripts will likely be impacted as our clients focus on responding to the pandemic and caring for their patients. However, we believe Allscripts’ agility and prior strategic platform investments prepare us to handle the challenges resulting from this global uncertainty. We fully intend to align with existing and new clients to capitalize on opportunities to deploy value-added solutions. Allscripts has multiple competitive advantages, including a robust solutions portfolio, a diversified global client base and high recurring revenues, positioning us well as we chart the path back to a more normalized operating environment.”

2020 Financial Outlook

Given the current uncertainty presented by the COVID-19 pandemic, Allscripts is withdrawing its prior financial outlook for the full-year 2020.

Conference Call

Allscripts will conduct a conference call today, Thursday, May 7th, 2020, at 4:30 PM Eastern Time to discuss its earnings release and other information. Participants may access the conference call via webcast at http://investor.allscripts.com. Participants also may access the conference call by dialing +1 (877) 269-7756 or +1 (201) 689-7817 (international) and requesting Conference ID # 13701343.

A replay of the call will be available approximately two hours after the conclusion of the call, for a period of four weeks, on the Allscripts Investor Relations website or by calling +1 (877) 660-6853 or +1 (201) 612-7415 – Conference ID # 13701343.

Supplemental and non-GAAP financial information is also available at http://investor.allscripts.com.

Footnotes

(1)

Bookings have been determined on a continuing operations basis and reflect the value of executed contracts for software, hardware, client services, private cloud hosting services, outsourcing and other subscription-based services.

NOTE: All percentage changes described within this press release are calculated from full dollar amounts as illustrated in the accompanying financial statements and Allscripts Supplemental Financial Data Workbook, posted on the Investor Relations website. Rounding differences may occur when individually calculating percentages or totals from rounded amounts included within the press release body compared to full dollar amounts in the tables.

About Allscripts

Allscripts (Nasdaq: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2020 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements under “2020 Financial Outlook”. These forward-looking statements are based on the current beliefs and expectations of Allscripts management, only speak as of the date that they are made and are subject to significant risks and uncertainties. Such statements can be identified by the use of words such as “future,” “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “will,” “would,” “could,” “can,” “may,” and similar terms. Actual results could differ significantly from those set forth in the forward-looking statements and reported results should not be considered an indication of future performance. Certain factors that could cause Allscripts actual results to differ materially from those described in the forward-looking statements include, but are not limited to: the magnitude, severity and duration of the COVID-19 pandemic, including the impacts of the pandemic, along with the impacts of our responses and the responses by governments and other businesses to the pandemic, on our business, our employees, our clients and our suppliers; the failure by Practice Fusion to comply with the terms of its settlement agreements with the U.S. Department of Justice (the “DOJ”); the costs and burdens of compliance by Practice Fusion with the terms of its settlement agreements with the DOJ; additional investigations and proceedings from governmental entities or third parties other than the DOJ related to the same or similar conduct underlying the DOJ’s investigations into Practice Fusion’s business practices; the expected financial results of businesses acquired by us; the successful integration of businesses recently acquired by us; the anticipated and unanticipated expenses and liabilities related to businesses acquired by us, including the civil investigation by the U.S. Attorney’s Office involving our EIS business; security breaches resulting in unauthorized access to our or our clients’ computer systems or data, including denial-of-services, ransomware or other Internet-based attacks; our failure to compete successfully; consolidation in our industry; current and future laws, regulations and industry initiatives; increased government involvement in our industry; the failure of markets in which we operate to develop as quickly as expected; our or our customers’ failure to see the benefits of government programs; changes in interoperability or other regulatory standards; the effects of the realignment of our sales, services and support organizations; market acceptance of our products and services; the unpredictability of the sales and implementation cycles for our products and services; our ability to manage future growth; our ability to introduce new products and services; our ability to establish and maintain strategic relationships; the performance of our products; our ability to protect its intellectual property rights; the outcome of legal proceedings involving us; our ability to hire, retain and motivate key personnel; performance by our content and service providers; liability for use of content; price reductions; our ability to license and integrate third party technologies; our ability to maintain or expand our business with existing customers; risks related to international operations; changes in tax rates or laws; business disruptions; our ability to maintain proper and effective internal controls; and asset and long-term investment impairment charges. Additional information about these and other risks, uncertainties, and factors affecting our business is contained in our filings with the Securities and Exchange Commission, including under the caption “Risk Factors” in our most recent Allscripts Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Qs. Allscripts does not undertake to update forward-looking statements to reflect changed assumptions, the impact of circumstances or events that may arise after the date of the forward-looking statements, or other changes in its business, financial condition or operating results over time.

Table 1
Allscripts Healthcare Solutions, Inc.
Condensed Consolidated Balance Sheets
(In millions)
(Unaudited)
 

March 31,

 

December 31,

2020

 

2019

ASSETS
Current assets:
Cash and cash equivalents

$204.3

$129.6

Restricted cash

7.8

7.9

Accounts receivable, net

471.2

459.8

Contract assets

98.2

96.0

Prepaid expenses and other current assets

125.7

148.0

Total current assets

907.2

841.3

Fixed assets, net

81.8

88.3

Software development costs, net

250.4

243.9

Intangible assets, net

358.3

374.1

Goodwill

1,361.1

1,362.0

Deferred taxes, net

5.5

5.7

Contract assets – long-term

54.5

67.6

Right-of-use assets – operating leases

110.5

98.0

Other assets

123.6

124.8

Total assets

$3,252.9

$3,205.7

 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable

$79.2

$104.0

Accrued expenses

217.3

270.7

Accrued compensation and benefits

67.6

68.6

Deferred revenue

401.5

379.8

Current maturities of long-term debt

370.8

364.5

Current operating lease liabilities

21.9

23.1

Total current liabilities

1,158.3

1,210.7

Long-term debt

680.4

551.0

Deferred revenue

12.4

12.3

Deferred taxes, net

18.5

21.0

Long-term operating lease liabilities

108.1

95.2

Other liabilities

33.4

30.3

Total liabilities

2,011.1

1,920.5

Total stockholders’ equity

1,241.8

1,285.2

Total liabilities and stockholders’ equity

$3,252.9

$3,205.7

Table 2
Allscripts Healthcare Solutions, Inc.
Condensed Consolidated Statements of Operations
(In millions, except per share amounts)
(Unaudited)
 
Three Months Ended March 31,

2020

2019

Revenue:
Software delivery, support and maintenance

$263.6

 

$275.5

 

Client services

153.1

 

156.5

 

Total revenue

416.7

 

432.0

 

Cost of revenue:
Software delivery, support and maintenance

76.3

 

81.0

 

Client services

152.8

 

148.7

 

Amortization of software development and acquisition-related assets (a)

30.6

 

28.2

 

Total cost of revenue

259.7

 

257.9

 

Gross profit

157.0

 

174.1

 

Selling, general and administrative expenses

97.3

 

100.2

 

Research and development

62.2

 

64.3

 

Impairments

0.0

 

0.1

 

Amortization of intangible and acquisition-related assets

6.7

 

6.8

 

Income (loss) from operations

(9.2

)

2.7

 

Interest expense and other, net (b)

(11.7

)

(9.7

)

Recovery (impairment) on long-term investments

0.0

 

1.0

 

Equity in net income (loss) of unconsolidated investments

0.2

 

(0.1

)

Income (loss) before income taxes

(20.7

)

(6.1

)

Income tax (provision) benefit

0.3

 

(1.9

)

Net income (loss)

(20.4

)

(8.0

)

Net (income) loss attributable to non-controlling interest

0.0

 

0.4

 

Net Income (loss) attributable to Allscripts Healthcare Solutions, Inc. stockholders

($20.4

)

($7.6

)

 
Income (loss) earnings per share – basic

($0.13

)

($0.04

)

Income (loss) earnings per share – diluted

($0.13

)

($0.04

)

 
Weighted average common shares outstanding:
Basic

162.5

 

170.0

 

Diluted

162.5

 

170.0

 

 
Three Months Ended March 31,

2020

 

2019

 
(a) Amortization of software development and acquisition-related assets includes:
Amortization of capitalized software development costs

$22.0

 

$19.2

 

Amortization of acquisition-related intangible assets

8.6

 

9.0

 

Total amortization of software development and acquisition-related assets

$30.6

 

$28.2

 

 
(b) Interest expense and other, net are comprised of the following for the periods presented:
 
Non-cash charges to interest expense

$4.8

 

$3.3

 

Interest expense

6.5

 

6.2

 

Amortization of discounts and debt issuance costs

0.9

 

0.7

 

Other (income) loss, net

(0.5

)

(0.5

)

Total interest expense and other, net

$11.7

 

$9.7

 

Table 3
Allscripts Healthcare Solutions, Inc.
Condensed Consolidated Statements of Cash Flows
(In millions)
(Unaudited)
 
Three Months Ended March 31,

2020

 

2019

 

Cash flows from operating activities:
Net income (loss)

($20.4

)

($8.0

)

Non-cash adjustments to net income (loss):
Depreciation and amortization

52.1

 

50.1

 

Operating right-to-use asset amortization

5.6

 

5.3

 

Stock-based compensation expense

10.0

 

11.7

 

Deferred Taxes

(2.1

)

0.0

 

Asset impairment charges

0.0

 

0.1

 

Impairment (recovery) of long-term investments

0.0

 

(1.0

)

Other loss (income), net

0.3

 

0.2

 

Total non-cash adjustments to net income (loss)

65.9

 

66.4

 

Cash impact of changes in operating assets and liabilities:
Assets

25.3

 

36.0

 

Liabilities

(17.2

)

(58.6

)

Accrued DOJ settlement

(57.3

)

0.0

 

Total cash impact of changes on operating assets and liabilities

(49.2

)

(22.6

)

Net cash provided by (used in) operating activities – continuing operations

(3.7

)

35.8

 

Net cash provided by (used in) operating activities – discontinued operations

0.0

 

(30.0

)

Net cash provide by (used in) operating activities

(3.7

)

5.8

 

Cash flows from investing activities:
Capital expenditures

(2.8

)

(4.8

)

Capitalized software

(28.6

)

(28.6

)

(Purchases) sales of equity securities in partner entities, business
acquisitions, net of cash acquired and other investments

(3.0

)

0.0

 

Other proceeds from investing activities

0.0

 

0.0

 

Net cash provided by (used in) investing activities

(34.4

)

(33.4

)

Cash flows from financing activities:
Taxes paid related to net share settlement of equity awards

(3.2

)

(5.3

)

Proceeds from issuance of 0.875% Convertible Senior Notes

(0.8

)

0.0

 

Credit facility payments

(80.0

)

(5.0

)

Credit facility borrowings, net of issuance costs

210.0

 

120.0

 

Repurchase of common stock

(9.7

)

(65.1

)

Payment of acquisition and other financing obligations

(2.9

)

(0.1

)

Purchases of subsidiary shares owned by non-controlling interest

0.0

 

(54.0

)

Net cash provided by (used in) financing activities

113.4

 

(9.5

)

Effect of exchange rate changes on cash and cash equivalents

(0.7

)

0.2

 

Net increase (decrease) in cash and cash equivalents

74.6

 

(36.9

)

Cash and cash equivalents, beginning of period

137.5

 

184.8

 

Cash and cash equivalents, end of period

$212.1

 

$147.9

 

 
Table 4
Allscripts Healthcare Solutions, Inc.
Condensed Non-GAAP Financial Information
(In millions, except per share amounts and percentages)
(Unaudited)
 

Three Months Ended March 31,

2020

2019

Total revenue, as reported

$416.7

 

$432.0

 

 
Acquisition-related deferred revenue adjustments

0.0

 

0.6

 

Total non-GAAP revenue

$416.7

 

$432.6

 

 
Gross profit, as reported

$157.0

 

$174.1

 

 
Acquisition-related deferred revenue adjustments

0.0

 

0.6

 

Acquisition-related amortization

8.6

 

9.0

 

Stock-based compensation expense

1.7

 

1.6

 

Restructuring and other

4.1

 

1.2

 

Total non-GAAP gross profit

$171.4

 

$186.5

 

 
Income (loss) from operations, as reported

($9.2

)

$2.7

 

 
Acquisition-related deferred revenue adjustments

0.0

 

0.6

 

Acquisition-related amortization

15.3

 

15.8

 

Stock-based compensation expense

11.1

 

12.8

 

Impairments

0.0

 

0.1

 

Restructuring and other

9.1

 

9.7

 

Total non-GAAP operating income

$26.3

 

$41.7

 

 
Net income (loss) attributable to Allscripts Healthcare Solutions, Inc. stockholders, as reported

($20.4

)

($8.0

)

Net (income) loss attributable to non-controlling interest

0.0

 

0.4

 

Income (loss), net of tax

($20.4

)

($7.6

)

 
Acquisition-related deferred revenue adjustments

0.0

 

0.6

 

Acquisition-related amortization

15.3

 

15.8

 

Stock-based compensation expense

11.1

 

12.8

 

Restructuring and other

9.1

 

9.7

 

Non-cash charges to interest expense and other

5.7

 

3.3

 

Impairments

0.0

 

0.1

 

Impairment of long-term investments

0.0

 

(1.0

)

Equity in net loss (income) of unconsolidated investments

(0.2

)

0.1

 

Tax rate alignment

(5.2

)

(6.6

)

Non-GAAP net (income)/loss attributable to non-controlling interest

0.0

 

(0.3

)

Non-GAAP net income attributable to Allscripts Healthcare Solutions, Inc.

$15.4

 

$26.9

 

 
Non-GAAP effective tax rate

24

%

24

%

 
Weighted shares outstanding – basic

162.5

 

170.0

 

Weighted shares outstanding – diluted

163.7

 

171.8

 

 
GAAP Income (loss) earnings per share – diluted

($0.13

)

($0.04

)

Non-GAAP Income (loss) earnings per share – diluted

$0.09

 

$0.16

 

Table 5
Allscripts Healthcare Solutions, Inc.
Non-GAAP Financial Information – Adjusted EBITDA
(In millions, except percentages)
(Unaudited)
 
Three Months Ended March 31,

2020

2019

Net income (loss), as reported

($20.4

)

($8.0

)

Plus:
Interest expense and other, net (a)

5.8

 

5.7

 

Depreciation and amortization

52.1

 

50.1

 

Equity in net (income) loss of unconsolidated investments

(0.2

)

0.1

 

Tax provision/(benefit)

(0.3

)

1.9

 

EBITDA

$37.0

 

$49.8

 

Plus:
Acquisition-related deferred revenue adjustments

0.0

 

0.6

 

Stock-based compensation expense

11.1

 

12.8

 

Restructuring and other

9.1

 

9.7

 

Impairments

0.0

 

0.1

 

(Recovery) impairment on long-term investments

0.0

 

(1.0

)

Adjusted EBITDA

$57.2

 

$72.0

 

 
Adjusted EBITDA margin (b)

14

%

17

%

(a) Interest expense and other, net has been adjusted from the amounts presented in the statements of operations in order to remove the amortization of the fair value of the cash conversion option embedded in the 1.25% and .875% Cash Convertible Notes and deferred debt issuance costs from interest expense since such amortization is also included in depreciation and amortization.
 
(b) Adjusted EBITDA margin is calculated by dividing adjusted EBITDA by non-GAAP revenue.

Explanation of Non-GAAP Financial Measures

Allscripts reports its financial results in accordance with U.S. generally accepted accounting principles, or GAAP. To supplement this information, Allscripts presents non-GAAP revenue, gross profit, gross margin, operating expense, income from operations, Adjusted EBITDA, effective income tax rate, net income, diluted earnings per share and free cash flow, which are considered non-GAAP financial measures under Section 101 of Regulation G under the Securities Exchange Act of 1934, as amended. The definitions of non-GAAP financial measures are presented below:

  • Non-GAAP revenue consists of GAAP revenue, as reported, and adds back recognized deferred revenue from the EIS business, Practice Fusion, HealthGrid, NantHealth’s provider/patient solutions business and non-material consolidated affiliates that is eliminated for GAAP purposes due to purchase accounting adjustments. Reconciliations to GAAP revenue are found in Table 4 within this press release.
  • Non-GAAP gross profit consists of GAAP gross profit, as reported, and excludes acquisition-related deferred revenue adjustments, acquisition-related amortization, stock-based compensation expense and restructuring and other costs. Non-GAAP gross margin consists of non-GAAP gross profit as a percentage of non-GAAP revenue in the applicable period. Reconciliations to GAAP gross profit are found in Table 4 within this press release.
  • Non-GAAP operating expense consists of GAAP selling, general and administrative expenses (SG&A) and research and development expense (R&D), as reported, and excludes restructuring and other costs and stock-based compensation expense recorded to SG&A and R&D. Reconciliations to GAAP operating expense are found in Table 4 within this press release.
  • Non-GAAP income from operations consists of GAAP income from operations, as reported, and excludes acquisition-related deferred revenue adjustments, acquisition-related amortization, stock-based compensation expense, impairment charges and restructuring and other costs. Reconciliations to GAAP income from operations are found in Table 4 within this press release.
  • Adjusted EBITDA is a non-GAAP measure and consists of GAAP net income/(loss), as reported, and adjusts for: acquisition-related deferred revenue adjustments; depreciation and amortization; stock-based compensation expense; restructuring and other costs; non-cash long-term investment impairment charges; goodwill impairment charges; gain on sale of businesses, net; interest expense and other, net; equity in net earnings of unconsolidated investments; and tax provision (benefit). Reconciliations to GAAP net income/(loss) are found in Table 5 within this press release.
  • Non-GAAP effective income tax rate is based on non-GAAP pre-tax earnings and consists of the statutory federal income tax rate, Allscripts effective state income tax rate and adjustments for permanent differences.
  • Non-GAAP net income consists of GAAP net income/(loss), as reported, and adds back acquisition-related deferred revenue adjustments; acquisition-related amortization; stock-based compensation expense; restructuring and other costs; non-cash long-term investment impairment charges; non-cash charges to interest expense and other; impairment charges and equity in net earnings of unconsolidated investments. Non-GAAP net income also includes a GAAP to non-GAAP tax rate alignment adjustment. Reconciliations to GAAP net income/(loss) are found in Table 4 within this press release.
  • Non-GAAP net income attributable to Allscripts Healthcare Solutions, Inc. is a non-GAAP measure and consists of non-GAAP net income, as described above, with an adjustment to reduce non-GAAP net income for the percentage of non-controlling interest outside Allscripts ownership position.
  • Non-GAAP diluted earnings per share consist of non-GAAP net income, as defined above, divided by weighted shares outstanding – diluted during the applicable period.
  • Free cash flow consists of GAAP cash flows provided by operating activities in the applicable period, net of capital expenditures and capitalized software costs, including those incurred by businesses presented as discontinued operations.

Acquisition-Related Deferred Revenue Adjustments. Deferred revenue adjustments include acquisition-related deferred revenue adjustments, which reflect the fair value adjustments to deferred revenue acquired in a business acquisition. The fair value of acquired deferred revenue represents an amount equivalent to the estimated cost plus an appropriate profit margin, to perform services related to the acquiree’s software and product support, which assumes a legal obligation to do so, based on the deferred revenue balances as of the acquisition date. Allscripts adds back acquisition-related deferred revenue adjustments for its non-GAAP financial measures because it believes the inclusion of this amount directly correlates to the underlying performance of Allscripts operations.

Acquisition-Related Amortization. Acquisition-related amortization expense is a non-cash expense arising primarily from the acquisition of intangible assets in connection with acquisitions or investments. Allscripts excludes acquisition-related amortization expense from non-GAAP gross profit, non-GAAP operating income, and non-GAAP net income because it believes (i) the amount of such expenses in any specific period may not directly correlate to the underlying performance of Allscripts business operations and (ii) such expenses can vary significantly between periods because of new acquisitions and full amortization of previously acquired intangible assets. Investors should note that the use of these intangible assets contributed to revenue in the periods presented and will contribute to future revenue generation, and the related amortization expense will recur in future periods.

Stock-Based Compensation Expense. Stock-based compensation expense is a non-cash expense arising from the grant of stock-based awards. Allscripts excludes stock-based compensation expense from non-GAAP gross profit, non-GAAP operating income, non-GAAP operating expense, non-GAAP net income and Adjusted EBITDA because it believes (i) the amount of such expenses in any specific period may not directly correlate to the underlying performance of Allscripts business operations and (ii) such expenses can vary significantly between periods as a result of the timing and valuation of grants of new stock-based awards, including grants in connection with acquisitions. Investors should note that stock-based compensation is a key incentive offered to employees whose efforts contributed to the operating results in the periods presented and are expected to contribute to operating results in future periods, and such expense will recur in future periods.

Impairments. Impairment charges reflect the write-off of the book value of certain fixed assets that resulted from consolidating business functions and data centers.

Restructuring and Other Costs. Restructuring and other costs relate to certain legal proceedings and investigations, consulting, severance, incentive compensation and other charges incurred in connection with activities that are considered not reflective of our core business.

Allscripts excludes restructuring and other costs, in whole or in part, from non-GAAP gross profit, non-GAAP operating income, non-GAAP operating expense, non-GAAP net income and Adjusted EBITDA because it believes (i) the amount of such expenses in any specific period may not directly correlate to the underlying performance of Allscripts business operations and (ii) such expenses can vary significantly between periods.

Non-Cash Charges to Interest Expense and Other. Non-cash charges to interest expense include the amortization of the fair value of the conversion option embedded in the 1.25 percent Cash Convertible Notes and 0.875 percent Convertible Notes issued by Allscripts during the second quarter of 2013 and fourth quarter of 2019, respectively.

Impairment of Long-Term Investments. Impairment of long-term investments relates to other-than-temporary non-cash impairment charges associated with such investments based on management’s assessment of the likelihood of near-term recovery of the investments’ value.

Equity in Net loss (income) of Unconsolidated Investments. Equity in net loss (income) of unconsolidated investments represents Allscripts share of the equity earnings of our investments in third parties accounted for under the equity method, including the amortization of cost basis adjustments.

Tax Rate Alignment. Tax rate alignment aligns the applicable period’s effective tax rate to the expected annual non-GAAP effective tax rate.

Management also believes that non-GAAP revenue, gross profit, gross margin, operating expense, income from operations, effective income tax rate, net income, diluted earnings per share, Adjusted EBITDA, and free cash flow provide useful supplemental information to management and investors regarding the underlying performance of Allscripts business operations. Acquisition accounting adjustments made in accordance with GAAP can make it difficult to make meaningful comparisons of the underlying operations of the business without considering the non-GAAP adjustments provided and discussed herein.

Management also uses this information internally for forecasting and budgeting, as it believes that these measures are indicative of core operating results. In addition, management may use non-GAAP gross profit, operating expense, operating income, net income, earnings per share and/or Adjusted EBITDA to measure achievement under Allscripts stock and cash incentive compensation plans. Note, however, that non-GAAP gross profit, operating income, net income, diluted earnings per share and Adjusted EBITDA are performance measures only, and they do not provide any measure of cash flow or liquidity. Allscripts considers free cash flow to be a liquidity measure that provides useful information to management and investors about the amount of cash generated by the business after capital expenditures and capitalized software costs. Free cash flow provides management and investors a valuable measure to determine the quantity of capital generated that can be deployed to create additional shareholder value by a variety of means. Non-GAAP financial measures are not in accordance with, or an alternative for, measures of financial performance prepared in accordance with GAAP and may be different from non-GAAP measures used by other companies. Non-GAAP measures have limitations in that they do not reflect all of the amounts associated with Allscripts results of operations as determined in accordance with GAAP. Investors and potential investors are encouraged to review the definitions and reconciliations of non-GAAP financial measures with GAAP financial measures contained within the attached condensed consolidated financial statements.

Investors:

Stephen Shulstein

312-386-6735

stephen.shulstein@allscripts.com

Media:

Concetta Rasiarmos

312-447-2466

concetta.rasiarmos@allscripts.com

Source: Allscripts Healthcare Solutions, Inc.

05/06/2020

Allscripts Tops Competitors in New Client Satisfaction Report From Black Book™ Research

Company earns fourth consecutive top client satisfaction rating as Top Inpatient EHR Vendor for Community Hospitals in 2020 Black Book survey

CHICAGO–(BUSINESS WIRE)–May 6, 2020–
Allscripts (NASDAQ: MDRX) has been recognized as the top-rated inpatient EHR vendor for hospitals 101-250 beds, according to new survey results from Black Book Research.

An annual survey of user experience and client constancy, the report features responses collected from 319 community health systems and hospitals, more than one-fifth of all community hospitals in the U.S. Based on responses from more than 2,000 individual users of electronic health records, Allscripts ranked number one in 10 of 18 client satisfaction key performance indicators compared with top competitors.

Allscripts earned the #1 ranking in categories including: Innovation & Optimization; Trust, Accountability, Transparency, Ethics; Reliability; and Best of Breed Technology and Process Improvement.

In addition, Allscripts also achieved top ratings for integrated cloud EHR revenue cycle management offerings to small hospitals and top ratings for rehabilitation health systems, according to Black Book.

“Allscripts regularly ranks above other leading HIT vendors in client satisfaction, which speaks to the company’s focus on ensuring its clients have what they need to care for their patients,” said Doug Brown, Managing Partner and President, Black Book. “The consistent results show a company both focused on meeting the needs of its clients both today and for the long-term.”

“Our success has always been powered by our unwavering commitment to our clients and the role we play helping enable positive outcomes for their patient communities,” said Paul Black, Allscripts CEO. “I’m proud that Allscripts has earned top honors in client satisfaction four times running, especially considering Black Book’s extensive and objective methodology for conducting its surveys. That makes this recognition even more meaningful and shows that our partnership philosophy is yielding positive results with our client base.”

Black Book Research is a full-service healthcare-centric market research and public opinion research company and premier provider of competitive intelligence, market research, opinion mining, sentiment analysis, services evaluation and strategic consulting services to companies worldwide. To ensure survey integrity and accurate, comprehensive results, Black Book’s methodology is crowd-sourced and represents a broad spectrum of EHR users. For more information, visit www.blackbookmarketresearch.com.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2020 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Investors:

Stephen Shulstein

312-386-6735

Stephen.Shulstein@allscripts.com

Media:

Concetta Rasiarmos

312-447-2466

concetta.rasiarmos@allscripts.com

Source: Allscripts

05/05/2020

Allscripts Announces Move to Virtual Format for 2020 Annual Meeting of Stockholders

CHICAGO–(BUSINESS WIRE)–May 5, 2020–
Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) today announced that, due to the public health impact of the novel coronavirus (COVID-19) pandemic, related governmental actions and the importance of safeguarding the health of its stockholders, employees and representatives, Allscripts will hold its 2020 Annual Meeting of Stockholders (the “Annual Meeting”) solely by means of remote communication (i.e., a virtual-only meeting). Stockholders will not be able to attend the Annual Meeting in person.

The Annual Meeting will be held on Thursday, May 21, 2020 at 9:00 a.m. Central time (10:00 a.m. Eastern time) in a virtual format only. As described in the proxy materials for the Annual Meeting previously distributed, stockholders as of the close of business on March 27, 2020, the record date, are entitled to participate in the Annual Meeting. Stockholders will need to register for the Annual Meeting by 10:59 p.m. Central time (11:59 p.m. Eastern time) on Monday, May 18, 2020 at http://viewproxy.com/AllscriptsHealthcareSolutions/2020. Stockholders who have properly registered and been verified will be given unique links that they will use to enter the virtual meeting.

A notice regarding the change to a virtual-only meeting (the “Notice”) is being filed with the Securities and Exchange Commission together with this press release. Additional information regarding the Annual Meeting, the registration process and voting is provided in the Notice.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2020 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Investors:

Stephen Shulstein

312-386-6735

Stephen.Shulstein@allscripts.com

Media:

Concetta Rasiarmos

312-447-2466

concetta.rasiarmos@allscripts.com

Source: Allscripts Healthcare Solutions, Inc.

04/30/2020

EPSi Releases Covid-19 Planning Analytics Tool

Designed and created for health systems to dynamically forecast and plan for local market COVID-19 conditions leveraging national, state, and county level data along with advanced analytic techniques.

CHICAGO–(BUSINESS WIRE)–Apr. 30, 2020–
EPSi, Allscripts’ (NASDAQ: MDRX) flagship budgeting, planning/forecasting, cost accounting and financial decision support platform, announced the release of its COVID-19 Planning Analytics tool. Initially, the tool will be made available to EPSi’s 1,000+ hospital clients at no cost. The COVID-19 Planning Analytics tool includes five independent analyses focused on answering the tough questions being asked by health system leaders across the country – When will we run out of ICU capacity? What is the financial burden of COVID and how does this change with duration? When can I resume elective procedures? How much do I need to reduce costs in my remaining budget to return to baseline?

“When we heard that many of our clients were struggling trying to respond to the unprecedented challenges they faced with the COVID-19 pandemic, we partnered with a group of strategic finance and operations leaders in our client base to discuss their analytic requirements and quickly realized there were no off the shelf products that met their needs,” said Ralph Keiser, CEO of EPSi. “Through several weeks of interactive discussion and design, our team created a series of analytic dashboards to enable users to model the impact of COVID-19 to their patient population, as well as the financial and operational impact to their organization.”

“In partnership with our clients, we rapidly designed and rolled out several iterations of the tool,” said Ryan Self, Vice President of Professional Services at EPSi. “The first version we released focuses on 5 key themes:

  • Current Market Insights Provides state and county level detail into current COVID-19 cases and deaths, changes over time, and frequency indexed by populous. Also enables the ability to compare growth rates between states, normalized to ‘Day 1’ along with analyze volume and growth rate changes based upon various time periods.
  • Case Projections Leverage multiple forecasting techniques to model out COVID-19 cases, admissions, and patient days by accommodation code. Compare results against bed capacity to determine shortages by accommodation code along with anticipated dates in which capacity is restored to backfill the beds and begin the road to revenue recovery.
  • Financial Planning – Project out daily NPSR, cash, expense burn, and ultimately margin for insights into the financial impacts and ramifications of COVID-19 cases.
  • Operational Planning – Similarly, project out daily staffing, vent, and PPE needs to ensure adequate planning and resource availability before the surge.
  • Arc of the Possible – Study the ‘Arc of the Possible’ to understand the effort required to bring the health system back to financial recovery and the appropriate balance of energy between expense reduction with margin growth efforts.”

“The EPSi COVID-19 Planning Analytics tool is available at no cost to EPSi clients for the next 90 days through generous sponsorships by our partners at AWS and Tableau, who have underwritten the cost of the technology,” said Keiser. All EPSi Clients may access the tool by registering at https://epsi.io/go/covid-19-analytics/

About EPSi EPSi is the industry leader in integrated healthcare decision analytics, budgeting, and planning solutions. More than 1,000 hospitals in the U.S., including nine of the top 10 rated hospitals, 128 IDN systems, and 40 global academic facilities, rely on EPSi for data-driven insight into managing costs and improving their long-range financial performance. Learn more about EPSi at www.epsi.io.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2020 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

For more information, contact:

Investors:

Stephen Shulstein

312-386-6735

Stephen.Shulstein@allscripts.com

Media:

Concetta Rasiarmos

312-447-2466

concetta.rasiarmos@allscripts.com

Source: Allscripts

04/29/2020

Veradigm Dedicated to Helping Combat COVID-19

Veradigm is working daily to help defeat COVID-19; supporting providers on the front line with tools to better manage their patients as well as arming researchers with patient data to enable a better understanding of virus patterns, symptoms, treatments and outcomes

CHICAGO–(BUSINESS WIRE)–Apr. 29, 2020–
As a leading provider of data and technology solutions, Allscripts (NASDAQ: MDRX) business unit, Veradigm, is at the forefront of the fight to help providers and researchers, and the patients they serve. The company is committed to leveraging its technology to help providers identify patients at risk for the virus and ensure they have the information and tools needed to help them. In addition, Veradigm is a founding member of a consortium dedicated to providing the data necessary for advancing COVID research.

COVID-19 Research Database

Veradigm is a founding collaborator of a consortium of leading healthcare companies who announced the launch of the COVID-19 Research Database earlier this week. The COVID-19 Research Database is a repository of HIPAA-compliant, de-identified and limited patient-level data sets that are intended to be made available to public health and policy researchers pro-bono, enabling them to extract insights to help combat the COVID-19 pandemic. As a collaborator of the consortium, Veradigm has committed to provide de-identified EHR patient data for nearly 60 million U.S. patients with a recent encounter.

COVID-19 Clinical Workflow Initiatives

Among its early efforts to help physicians identify patients at risk, Veradigm implemented a reminder that appears during the EHR log in process reminding providers to ask patients about recent travel and potential exposure when they present symptoms associated with COVID-19. It also began alerting physicians when a diagnostic code they enter for a patient aligns with CDC clinical criteria for COVID-19. The alert is displayed prominently, signals to the physician that the diagnosis is associated with COVID-19 and provides a link to CDC guidelines.

Most recently, Veradigm began deploying free video-conferencing services to its EHR providers, enabling them to deliver services during the peak period of this crisis through telemedicine, and helping control further contamination. Over the past months, Veradigm has offered valuable patient engagement tools to its customers, such as HIPAA-compliant secure texting and broadcast messaging.

Other initiatives Veradigm has taken include:

  • Implementing COVID-19 questionnaires within the software that enable documentation of current symptoms, recent travel outside the country and more.
  • Establishing a connection to the CDC website from within several places in the provider workflow within the EHR.
  • Launching a Physician and Patient resource section within its website that includes information on preparedness, screening and testing, prevention and control, management and treatment and patient education.
  • Offering providers video chat services to support telehealth.
  • Providing ePrescribe software that is EHR agnostic and can be used by any practice even if they don’t use its EHR.
  • Implementing changes to development process, enabling Veradigm to be swifter in implementing new alerts, diagnostic codes and other related efforts into the workflow of its EHR.

Veradigm is also continuing its long-standing policy to offer its EHR services free of charge to the local Free Clinics who are at the front line of this pandemic.

“We, at Veradigm, pledge to do our utmost to maintain the highest levels of service, reliability, and insight for patients and the providers that serve them,” said Veradigm CEO, Tom Langan. “Our solutions are an integral part of toolsets that medical professionals are using to care for their patients, whether in person or telehealth.”

About Veradigm™

Veradigm is an integrated data systems and services company that combines data-driven clinical insights with actionable tools to help healthcare stakeholders improve the quality, efficiency, and value of healthcare delivery— including biopharma, health plans, healthcare providers, health technology partners, and most importantly, the patients they serve. We are dedicated to simplifying the complicated healthcare system with next-generation healthcare solutions. This is how we are transforming health, insightfully. To learn more, visit www.veradigmhealth.com.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2020 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

For more information contact:

Investors:

Stephen Shulstein

312-386-6735

Stephen.Shulstein@allscripts.com

Media:

Concetta Rasiarmos

312-447-2466

concetta.rasiarmos@allscripts.com

Source: Allscripts

04/27/2020

Allscripts to Release First-Quarter 2020 Financial Results May 7

CHICAGO–(BUSINESS WIRE)–Apr. 27, 2020–
Allscripts Healthcare Solutions, Inc. (Nasdaq:MDRX) will report its financial results for the three months ended March 31, 2020 after the close of stock market hours on Thursday, May 7, 2020. Allscripts management plans to host a conference call and webcast to discuss the company’s earnings and other information at 4:30 p.m. Eastern Time that same day.

First-Quarter 2020 Financial Results Call Details

The Allscripts earnings announcement will be distributed immediately after the close of regular stock market hours on Thursday, May 7, 2020. The announcement will also be available at Allscripts investor relations website.

To listen to the conference call, participants may log onto the Allscripts Investor Relations website. Participants also may access the conference call by dialing (877) 269-7756 or (201) 689-7817 and requesting Conference ID # 13701343.

A replay of the call will be available approximately two hours after the conclusion of the call, for a period of four weeks, on the Allscripts investor relations website or by calling (877) 660-6853 or (201) 612-7415 – Conference ID # 13701343.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2020 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

For more information contact:

Investors:

Stephen Shulstein

312-386-6735

Stephen.Shulstein@allscripts.com

Media:

Concetta Rasiarmos

312-447-2466

concetta.rasiarmos@allscripts.com

Source: Allscripts Healthcare Solutions, Inc.

03/30/2020

Allscripts helps U.S. healthcare organizations rapidly implement telehealth support for virtual patient visits

Company offers streamlined telehealth implementation to health systems through its EHR-agnostic patient engagement platform, Allscripts FollowMyHealth®, amid COVID-19

CHICAGO–(BUSINESS WIRE)–Mar. 30, 2020–
Allscripts (NASDAQ: MDRX) clients across the nation have signed up to deliver telehealth visit capabilities in a quick timeframe to their patients. The company has created a specialized plan for clients to swiftly implement telehealth at their organizations through its EHR-agnostic patient engagement platform, FollowMyHealth.

In the last month, more than 100 clients have selected, and more than 50 clients have already implemented, FollowMyHealth Telehealth. The solution allows for the engagement of patients in their homes and enables communication between quarantined people and sponsoring healthcare organizations.

By converting appointments to telehealth, the solution limits interactions that could further spread the COVID-19 virus to patients and healthcare workers, as well as provides peace of mind to patients who are able to use telehealth visits and limit their exposure in times of this outbreak. In addition, the solution can help limit no-shows and cancellations while delivering care to those in need. During the COVID-19 crisis, Allscripts clients have increased the number of video visits by 9,000%.

This expedited implementation includes a step-by-step client decision workbook, 10 remote project hours for training, a specialized COVID-19 form and alert verbiage for patient outreach, enabling clients to be up and running in a matter of days. The average installation is less than 5 days from contract to go-live. The FollowMyHealth solution follows recommendations made by the CDC to proactively reach out to triage patients prior to appointments and explore alternatives to face-to-face visits.

“With our telehealth offering through the robust FollowMyHealth platform, Allscripts is helping clients adapt to the evolving healthcare environment by redefining how healthcare professionals interact with and engage their patients,” said Allscripts EVP and GM of FollowMyHealth, Jim Hewitt. “We’re committed to partnering with healthcare organizations to help combat the spread of COVID-19 by providing them with telehealth solutions that deliver innovative ways to care for their patients in need.”

Hewitt added, “Our consumer engagement strategy has an EMR-agnostic patient record at its core. That record is connected to the consumer’s care team. That is why we architected a platform approach to our telemedicine solutions. This strategy contrasts favorably to a bunch of ‘cool apps’ that further perpetuate isolated silos of inoperable data.”

Grand Lake Health System and its affiliated health centers are organized as a charitable, non-profit comprehensive community hospital offering a wide range of primary, acute and rehabilitative services to the residents of the Grand Lake region. Grand Lake and Allscripts worked to execute a contract on March 17, immediately staffed and began implementation of the project on the same day, which was followed by live activation less than two days later. Grand Lake has been using the solution with more than 100 visits (both scheduled video visits and on-demand visits) just in the first few days of activation.

“Allscripts was very responsive to our needs to quickly roll out telehealth at our organization, in light of the COVID-19 pandemic,” said Grand Lake Health System’s Chief of Information Services, Lori Miller, RHIA. “This was a quick install and has been easily rolled out to our ambulatory providers as well as several of our acute outpatient service areas. This has been a welcomed transition for many of our patients that are diligently practicing social distancing.”

The Los Angeles LGBT Center has seen success by partnering with Allscripts to support a “telehealth first” strategy with its patients in response to the COVID-19 pandemic.

“Allscripts has been efficient with expediting our telehealth setup which gives us more ways to keep our patients and our staff safe at home,” said Gabriel Lopez, Los Angeles LGBT Center’s Director of Health Information Systems. “With FollowMyHealth we have enabled, tested, and successfully piloted telehealth visits within three days, and we anticipate most of our 48 medical and mental health providers to have the capability to accept video visits by the end of March. Our partnership with Allscripts is helping LGBT people thrive as healthy, equal, and complete members of society.”

Brad Holland, President and CEO of Hendrick Health System in Abilene, TX, said, “Because this unprecedented health crisis has deterred patients from seeing their providers, it’s never been more critical for healthcare organizations to utilize available telehealth capabilities. With FollowMyHealth, we have been able to reach our patients while they remain safe in their homes. It’s a tool that has proven vital in our efforts to flatten the curve of COVID-19.”

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2020 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Investors:

Stephen Shulstein

312-386-6735

Stephen.Shulstein@allscripts.com

Media:

Concetta Rasiarmos

312-447-2466

concetta.rasiarmos@allscripts.com

Source: Allscripts

03/26/2020

CarePort enables safe transitions of care during COVID-19 outbreak

Launches industry resource providing current learnings, latest trends and best practices from 1,000 hospitals and 180,000 post-acute providers are now available through CarePort’s COVID-19 Transitions of Care Hub

CHICAGO–(BUSINESS WIRE)–Mar. 26, 2020–
CarePort Health, a wholly-owned subsidiary of Allscripts (NASDAQ: MDRX) that connects 1,000 hospitals with 180,000 post-acute providers, is launching the COVID-19 Transitions of Care (“TOC”) Hub as an educational resource to share current learnings, latest trends and best practices for safe and effective transitions for COVID-19 patients across the healthcare system. Hospitals across the US send 18 million referrals annually through CarePort to skilled nursing, home health, hospice, long-term acute and acute rehabilitation, which accounts for nearly 40% of all acute to post-acute transitions nationally. Given that CarePort customers are on the front lines of the pandemic, the TOC Hub aims to disseminate critical lessons learned in real time.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200326005650/en/

“The COVID-19 pandemic presents unchartered territory for hospital and post-acute providers, and CarePort and Allscripts are supporting our partners’ most pressing needs in the fight against this disease,” said Allscripts Chief Executive Officer Paul Black. “Leveraging the largest network of connected acute and post-acute providers, CarePort technology is already being used on the front lines to support safe and efficient patient transitions during the COVID-19 outbreak.”

The following insights are currently highlighted in the COVID-19 Transitions of Care Hub:

More visibility on COVID-19 hospitalizations needed

In the Centers for Disease Control and Prevention’s March 18, 2020 Morbidity and Mortality Weekly Report, while 508 hospitalizations were reported, 1,514 cases were missing hospitalization status. Leveraging representative data from across CarePort’s customer base, CarePort analysis shows 777 confirmed COVID-19 diagnoses and an additional 3,726 suspected cases hospitalized last week alone. In an effort to provide more visibility to COVID-19 hospitalizations, CarePort will publish ongoing reports on COVID-19 trends across its acute and post-acute providers in 43 states.

Providers seek notifications on COVID-19 patients who may be diagnosed in outside hospitals

Hospitals may be aware of COVID-19 diagnoses at their own facilities, but patients often seek care at outside hospitals, and even across state lines. Given our national network of hospitals and post-acute providers, CarePort is enabling providers in our network to receive alerts when a patient with whom they had an encounter is diagnosed with COVID-19. As a best practice, real-time alerts are also being sent to the primary care physician so that they can ensure appropriate follow-up care.

Finding nursing homes for COVID-19 patients is creating bottlenecks in hospitals

In areas where there is an influx of COVID-19 patients, finding post-acute providers that are willing and able to accept COVID-19 patients has been a challenge. CarePort is working with hospitals to reduce bottlenecks on the discharge end by identifying post-acute providers that are accepting or are currently caring for COVID-19 patients. Post-acute providers are updating on a daily basis their capacity to accept COVID-19 patients. CarePort is also providing clients with a COVID-19 assessment created by a client partner for patients referred to nursing homes. Nursing homes can use this information to easily identify whether they are able to accept the patient.

Hospitals are leveraging ways to help patients choose nursing homes virtually

Hospitals are restricting visitors, including family members who often play an important role in helping patients select a nursing home or other post-acute provider. Nursing homes are also no longer allowing tours that would normally take place. In response, CarePort has enabled hospitals to share nursing home options with families via text message or email. Family members, who otherwise would be on-site, can see an interactive guide that includes virtual tours and pictures to help their loved ones select the right post-acute provider.

Given CarePort’s extensive access to robust acute and post-acute data across its national network of providers, the COVID-19 Transitions of Care Hub will continue to monitor trends and share follow-up observations with the hope that this serves as a valuable resource to ensure safe and effective transitions of care for COVID-19 patients.

Visit CarePort’s COVID-19 Transitions of Care Hub at www.CovidTOC.com for critical insights updated in real-time.

About CarePort

CarePort is the leading care coordination network with thousands of providers connected across the US. Care teams use CarePort to manage transitions in care, enable ED diversion and readmission reduction programs, and oversee post-acute cost and outcomes by tracking populations in real-time across the continuum. The end-to-end platform bridges acute and post-acute EHRs, providing visibility and actionable intelligence so that providers and payers can efficiently and effectively coordinate patient care. Follow us on LinkedIn and Twitter.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2020 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Investors:

Stephen Shulstein

312-386-6735

Stephen.Shulstein@allscripts.com

Media:

Concetta Rasiarmos

312-447-2466

concetta.rasiarmos@allscripts.com

Source: Allscripts

Scroll To Top